These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 8475409)

  • 1. Cancer pharmacology in the elderly.
    Egorin MJ
    Semin Oncol; 1993 Feb; 20(1):43-9. PubMed ID: 8475409
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacology of antineoplastic agents in the elderly patient.
    Balducci L; Parker M; Sexton W; Tantranond P
    Semin Oncol; 1989 Feb; 16(1):76-84. PubMed ID: 2645652
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cancer chemotherapy in patients older than 75 years old--from the aspect of clinical pharmacology].
    Tanaka K; Okumura K
    Gan To Kagaku Ryoho; 1998 Jun; 25(7):995-9. PubMed ID: 9644313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacology issues relevant to the dosing and toxicity of chemotherapy drugs in the elderly.
    Wasil T; Lichtman SM
    Oncologist; 2005 Sep; 10(8):602-12. PubMed ID: 16177284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualizing dosing of cancer chemotherapy.
    Kobayashi K; Ratain MJ
    Semin Oncol; 1993 Feb; 20(1):30-42. PubMed ID: 8475408
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacology of anticancer drugs in the elderly: tools for dose-adjustment].
    Tranchand B; Falandry C; You B; Girard P; Ribba B; Tod M; Freyer G
    Bull Cancer; 2008 May; 95 FMC Onco():F21-7. PubMed ID: 18511363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer.
    Papandreou CN; Daliani DD; Nix D; Yang H; Madden T; Wang X; Pien CS; Millikan RE; Tu SM; Pagliaro L; Kim J; Adams J; Elliott P; Esseltine D; Petrusich A; Dieringer P; Perez C; Logothetis CJ
    J Clin Oncol; 2004 Jun; 22(11):2108-21. PubMed ID: 15169797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetically guided dose-escalation (PGDE) strategy].
    Saeki T
    Gan To Kagaku Ryoho; 2000 Jul; 27(7):1069-74. PubMed ID: 10925698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of antineoplastic medications in older cancer patients.
    Balducci L
    Oncology (Williston Park); 2009 Jan; 23(1):78-85. PubMed ID: 19283925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose adjustment and supportive care before and during treatment.
    Brunello A; Loaldi E; Balducci L
    Cancer Treat Rev; 2009 Oct; 35(6):493-8. PubMed ID: 19493625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy-induced neutropenia: a useful predictor of treatment efficacy?
    Di Maio M; Gridelli C; Gallo C; Perrone F
    Nat Clin Pract Oncol; 2006 Mar; 3(3):114-5. PubMed ID: 16520781
    [No Abstract]   [Full Text] [Related]  

  • 12. Finding the right dose.
    Ratain MJ
    Clin Adv Hematol Oncol; 2003 Sep; 1(9):517-8, 531. PubMed ID: 16258442
    [No Abstract]   [Full Text] [Related]  

  • 13. [Problems associated with molecular targeted drugs for cancer].
    Kawaishi M; Koizum F; Nishio K
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1373-9. PubMed ID: 17033223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer in the elderly population: the protection racket.
    Raghavan D; Suh T
    J Clin Oncol; 2006 Apr; 24(12):1795-6. PubMed ID: 16567764
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics in the elderly.
    Lichtman SM
    Clin Adv Hematol Oncol; 2007 Mar; 5(3):181-2. PubMed ID: 17519878
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase I trial of methotrexate-albumin in a weekly intravenous bolus regimen in cancer patients. Phase I Study Group of the Association for Medical Oncology of the German Cancer Society.
    Hartung G; Stehle G; Sinn H; Wunder A; Schrenk HH; Heeger S; Kränzle M; Edler L; Frei E; Fiebig HH; Heene DL; Maier-Borst W; Queisser W
    Clin Cancer Res; 1999 Apr; 5(4):753-9. PubMed ID: 10213209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dose individualization for carboplatin in cancer chemotherapy].
    Oudard S; Lauraine EP
    Bull Cancer; 1997 Jun; 84(6):675-7. PubMed ID: 9295872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rôle of clinical pharmacology in cancer chemotherapy: methods of administering drugs].
    Kenis Y
    Acta Chir Belg; 1971; Suppl 1():Suppl 1:29-41. PubMed ID: 5317699
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy insight: Therapeutic challenges in the treatment of elderly cancer patients.
    Lichtman SM
    Nat Clin Pract Oncol; 2006 Feb; 3(2):86-93. PubMed ID: 16462849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I clinical and pharmacokinetic study of Ro 31-7453 given as a 7- or 14-day oral twice daily schedule every 4 weeks in patients with solid tumors.
    Salazar R; Bissett D; Twelves C; Breimer L; DeMario M; Campbell S; Zhi J; Ritland S; Cassidy J
    Clin Cancer Res; 2004 Jul; 10(13):4374-82. PubMed ID: 15240525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.